Participated as an existing investor in Neuron23's $96.5M Series D financing for its Parkinson's disease pipeline.
JUN 24, 2025
Neuron23 is focused on developing precision medicine approaches to improve the lives of people with Parkinson’s disease, leveraging data science and human genetics
Neuron23 is focused on developing precision medicine approaches to improve the lives of people with Parkinson’s disease, leveraging data science and human genetics.